These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 9534020)

  • 1. Calcium sensitising agents in heart failure.
    Mathew L; Katz SD
    Drugs Aging; 1998 Mar; 12(3):191-204. PubMed ID: 9534020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levosimendan: a review of its use in the management of acute decompensated heart failure.
    Innes CA; Wagstaff AJ
    Drugs; 2003; 63(23):2651-71. PubMed ID: 14636085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Will calcium sensitizers play a role in the treatment of heart failure?
    Nielsen-Kudsk JE; Aldershvile J
    J Cardiovasc Pharmacol; 1995; 26 Suppl 1():S77-84. PubMed ID: 8907135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic treatment of heart failure due to ventricular dysfunction by myocardial stunning: potential role of levosimendan.
    García González MJ; Domínguez Rodríguez A
    Am J Cardiovasc Drugs; 2006; 6(2):69-75. PubMed ID: 16555860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levosimendan: beyond its simple inotropic effect in heart failure.
    Antoniades C; Tousoulis D; Koumallos N; Marinou K; Stefanadis C
    Pharmacol Ther; 2007 May; 114(2):184-97. PubMed ID: 17363065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The myofilament force-calcium relationship as a target for positive inotropic therapy in congestive heart failure.
    MacGowan GA
    Cardiovasc Drugs Ther; 2005 May; 19(3):203-10. PubMed ID: 16142598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Could Ca2+ sensitizers rescue patients from chronic congestive heart failure?
    Endoh M
    Br J Pharmacol; 2007 Apr; 150(7):826-8. PubMed ID: 17325657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inotropic agents for treatment of acute heart failure syndromes in intensive care].
    Rusca M; Liaudet L
    Rev Med Suisse; 2009 Dec; 5(229):2512-5. PubMed ID: 20084871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of Ca++-sensitizers for the treatment of heart failure.
    Lehmann A; Boldt J; Kirchner J
    Curr Opin Crit Care; 2003 Oct; 9(5):337-44. PubMed ID: 14508145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of levosimendan in the treatment of heart failure.
    Kasikcioglu HA; Cam N
    Vasc Health Risk Manag; 2006; 2(4):389-400. PubMed ID: 17323593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pimobendan and its use in treating canine congestive heart failure.
    Bowles D; Fry D
    Compend Contin Educ Vet; 2011 Nov; 33(11):E1. PubMed ID: 22101450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levosimendan in patients with low-output heart failure: lessons from the LIDO trial.
    Follath F
    Ital Heart J; 2003 May; 4 Suppl 2():34S-38S. PubMed ID: 14635368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart failure update.
    Gomes UC; Cleland JG
    Eur J Heart Fail; 1999 Aug; 1(3):301-2. PubMed ID: 10935680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levosimendan preoperative.
    Rognoni A; Lupi A; Cavallino C; Veia A; Bacchini S; Rosso R; Secco GG; Bongo AS
    Curr Pharm Des; 2013; 19(22):3974-8. PubMed ID: 23228313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The utility of levosimendan in the treatment of heart failure.
    Lehtonen L; Põder P
    Ann Med; 2007; 39(1):2-17. PubMed ID: 17364447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium sensitizer agents: a new class of inotropic agents in the treatment of decompensated heart failure.
    Perrone SV; Kaplinsky EJ
    Int J Cardiol; 2005 Sep; 103(3):248-55. PubMed ID: 16098385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of pimobendan on exercise tolerance and quality of life in patients with heart failure.
    Kubo SH
    Cardiology; 1997; 88 Suppl 2():21-7. PubMed ID: 9142432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A promising new inotrope: levosimendan.
    Fotbolcu H; Duman D
    Anadolu Kardiyol Derg; 2010 Apr; 10(2):176-82. PubMed ID: 20382619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pimobendan. A review of its pharmacology and therapeutic potential in congestive heart failure.
    Fitton A; Brogden RN
    Drugs Aging; 1994 May; 4(5):417-41. PubMed ID: 8043944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of heart failure patients with inotropic drugs: beyond traditional agents].
    Metra M; Lombardi C; Carubelli V; Bettari L; Bugatti S; Danesi R; Lazzarini V; Monti A; Villa C; Dei Cas L
    G Ital Cardiol (Rome); 2010 Oct; 11(10 Suppl 1):143S-148S. PubMed ID: 21416846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.